Brant Point Investment Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.42M | Sell |
41,242
-7,992
| -16% | -$663K | 0.36% | 54 |
|
|
2025
Q1 | $3.99M | Sell |
49,234
-616
| -1% | -$50K | 0.48% | 42 |
|
|
2024
Q4 | $4.49M | Hold |
49,850
| – | – | 0.56% | 40 |
|
|
2024
Q3 | $4.93M | Hold |
49,850
| – | – | 0.54% | 41 |
|
|
2024
Q2 | $4.62M | Buy |
49,850
+27,592
| +124% | +$2.56M | 0.41% | 41 |
|
|
2024
Q1 | $2.11M | Buy |
22,258
+5,000
| +29% | +$474K | 0.18% | 60 |
|
|
2023
Q4 | $1.54M | Sell |
17,258
-97
| -0.6% | -$8.66K | 0.13% | 64 |
|
|
2023
Q3 | $1.27M | Sell |
17,355
-347
| -2% | -$25.3K | 0.12% | 69 |
|
|
2023
Q2 | $1.47M | Sell |
17,702
-61
| -0.3% | -$5.08K | 0.34% | 65 |
|
|
2023
Q1 | $1.35M | Hold |
17,763
| – | – | 0.23% | 67 |
|
|
2022
Q4 | $1.47M | Sell |
17,763
-13,693
| -44% | -$1.14M | 0.22% | 59 |
|
|
2022
Q3 | $2.5M | Hold |
31,456
| – | – | 0.37% | 56 |
|
|
2022
Q2 | $2.34M | Sell |
31,456
-8,800
| -22% | -$654K | 0.35% | 54 |
|
|
2022
Q1 | $3.62M | Sell |
40,256
-20,000
| -33% | -$1.8M | 0.41% | 54 |
|
|
2021
Q4 | $6.75M | Buy |
60,256
+20,128
| +50% | +$2.25M | 1.06% | 32 |
|
|
2021
Q3 | $5.04M | Buy |
40,128
+8,128
| +25% | +$1.02M | 0.44% | 47 |
|
|
2021
Q2 | $4.33M | Hold |
32,000
| – | – | 0.4% | 63 |
|
|
2021
Q1 | $4.34M | Hold |
32,000
| – | – | 0.47% | 59 |
|
|
2020
Q4 | $4.51M | Hold |
32,000
| – | – | 0.53% | 53 |
|
|
2020
Q3 | $3.57M | Hold |
32,000
| – | – | 0.31% | 65 |
|
|
2020
Q2 | $3.58M | Buy |
+32,000
| New | +$3.58M | 0.35% | 55 |
|